This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Chu De Nice, Université De Nice Sophia Antipolis. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020
Title: Vincent Louis Marie Esnault: Innovator in Nephrology
Introduction
Vincent Louis Marie Esnault is a notable inventor based in Nice, France. He has made significant contributions to the field of nephrology, particularly in the prognosis and monitoring of membranous nephropathy. His innovative approach has the potential to enhance patient care and treatment outcomes.
Latest Patents
Esnault holds a patent titled "Prognosis and monitoring of membranous nephropathy based on the analysis of PLA2R1 epitope profile." This patent discloses a method for assessing the prognosis of idiopathic membranous nephropathy using a body fluid sample from a human subject. The method involves profiling PLA2R1 epitopes recognized by autoantibodies in the sample. It also analyzes PLA2R1 epitope spreading among three PLA2R1 domains, which are recognized by anti-PLA2R1 autoantibodies. Notably, two of these domains are closely associated with active idiopathic membranous nephropathy and are likely linked by a mechanism of epitope spreading.
Career Highlights
Throughout his career, Esnault has been affiliated with prestigious institutions such as Université de Nice Sophia Antipolis and the Centre National de la Recherche Scientifique. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Esnault has collaborated with esteemed colleagues, including Barbara Polski and Gérard Jean Frantz Lambeau. These partnerships have fostered a collaborative environment that enhances research and innovation in nephrology.
Conclusion
Vincent Louis Marie Esnault is a distinguished inventor whose work in nephrology has the potential to significantly impact patient prognosis and treatment. His innovative methods and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile